Sirio Pharma Co Ltd
SZSE:300791
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Sirio Pharma Co Ltd
SZSE:300791
|
6.7B CNY |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
211.5B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
117.2B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.6T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
34.1B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
41B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.5B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
918.8B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Sirio Pharma Co Ltd
Glance View
Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Sirio Pharma Co Ltd is 7.8%, which is in line with its 3-year median of 7.8%.
Over the last 3 years, Sirio Pharma Co Ltd’s Net Margin has decreased from 8.6% to 7.8%. During this period, it reached a low of 6.9% on Sep 30, 2023 and a high of 8.6% on Sep 30, 2022.
